ATLANTA BOTANICAL GARDEN, INC. THE – Trademark Portfolio
Entity Type: 03
ATLANTA BOTANICAL GARDEN, INC. THE holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ATLANTA BOTANICAL GARDEN. The owner is based in ATLANTA, GA.
BOX 77246
PIEDMONT PARK AT THE PRADO
ATLANTA, GA 30357
Showing of trademarks Trademarks
Trademark Classifications
ATLANTA BOTANICAL GARDEN, INC. THE's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does ATLANTA BOTANICAL GARDEN, INC. THE have?
ATLANTA BOTANICAL GARDEN, INC. THE has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does ATLANTA BOTANICAL GARDEN, INC. THE file in?
ATLANTA BOTANICAL GARDEN, INC. THE files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are ATLANTA BOTANICAL GARDEN, INC. THE's most well-known trademarks?
ATLANTA BOTANICAL GARDEN, INC. THE's registered trademark portfolio includes well-known marks such as ATLANTA BOTANICAL GARDEN. These are among 1 currently registered trademark in the portfolio.
What is ATLANTA BOTANICAL GARDEN, INC. THE's trademark registration success rate?
ATLANTA BOTANICAL GARDEN, INC. THE has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.